NanoString's GeoMx® Digital Spatial Profiling (DSP) platform has emerged as a key tool in the journey for better immuno-oncology drugs. Recent publications have highlighted research using this transcriptomic assay to analyze the tumor and tumor microenvironment enabling scientists to identify therapeutic targets and molecular biomarkers. This 15-minute webinar reviews case studies from the literature using GeoMx in IO drug discovery work. Canopy Biosciences is a premier NanoString GeoMx DSP CRO, running research, pre-clinical, and clinical studies using this platform.
Canopy Biosciences is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:
I agree to receive marketing communications from Canopy Biosciences.
You can unsubscribe from these communications at any time by clicking the Unsubscribe link at the bottom of any of the emails we've sent you. View our Privacy Policy for more information.
By clicking submit below, you consent to allow Canopy Biosciences to store and process the personal information submitted above to provide you the content requested.